Xavier Forns

Cap de la Unitat

Grup de recerca

Malalties hepàtiques víriques, genètiques i immuno-mediades Accredited researcher (R3A)

xforns@clinic.cat 0000-0002-8188-1764

Publicacions destacades

Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease.

Autors:
Rothhaar P; Arand T; Seong HG; Heuss C; Tulessin M;

(...)

Mogler C; McLauchlan J; Forns X; Pérez-Del-Pulgar S; Lohmann V.

Referència: Nature Communications 2025.
Incidence and Clinical Significance of Recompensation After HCV Cure

Autors:
Semmler, Georg; Lens, Sabela; Hidalgo, Alvaro; Lopez, Sonia Alonso; Perez-Perez, Maria;

(...)

Genesca, Joan; Banares, Rafael; Forns, Xavier; Fernandez, Inmaculada; Mandorfer, Mattias.

Referència: Clinical Gastroenterology and Hepatology 2025.
Exchangeable copper for patients with Wilson disease at follow-up: Rethinking normal ranges or changing methodology

Autors:
Marino, Zoe; Garcia-Sola, Claudia; Rios, Jose; Bono, Ariadna; Garcia, Sonia;

(...)

Andreu, Rocio; Aguado, Cristina; Forns, Xavier; Torra, Merce; Berenguer, Marina.

Referència: HEPATOLOGY 2025.
Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta

Autors:
Degasperi, Elisabetta; Scholtes, Caroline; Testoni, Barbara; Renteria, Sara Uceda; Anolli, Maria Paola;

(...)

Perez-del-Pulgar, Sofia; Heil, Marintha; Levrero, Massimo; Zoulim, Fabien; Lampertico, Pietro.

Referència: JOURNAL OF HEPATOLOGY 2025.
Predictors of hepatic flares after nucleos(t)ide analogue cessation - Results of a global cohort study (RETRACT-B study)

Autors:
Dongelmans, Edo J; Hirode, Grishma; Hansen, Bettina E; Chen, Chien-Hung; Su, Tung-Hung;

(...)

Kao, Jia-Horng; Cornberg, Markus; Sonneveld, Milan J; Jeng, Wen-Juei; Janssen, Harry L A.

Referència: JOURNAL OF HEPATOLOGY 2025.
EASL position paper on clinical follow-up after HCV cure

Autors:
Reiberger, Thomas; Lens, Sabela; Cabibbo, Giuseppe; Nahon, Pierre; Zignego, Anna Linda;

Deterding, Katja; Elsharkawy, Ahmed M; Forns, Xavier.

Referència: JOURNAL OF HEPATOLOGY 2024.
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure

Autors:
Semmler, Georg; Lopez, Sonia Alonso; Pons, Monica; Lens, Sabela; Dajti, Elton;

(...)

Reiberger, Thomas; Forns, Xavier; Genesca, Joan; Banares, Rafael; Mandorfer, Mattias.

Referència: JOURNAL OF HEPATOLOGY 2024.
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

Autors:
Ruiz-Cobo, Juan Carlos; Llaneras, Jordi; Forns, Xavier; Gallego Moya, Adolfo; Conde Amiel, Isabel;

(...)

Bernal-Monterde, Vanesa; Delgado, Manuel; Turnes, Juan; Lens, Sabela; Buti, Maria.

Referència: ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2024.
Off-therapy response after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B: An international, multi-center, multi-ethnic cohort (RETRACT-B study)

Autors:
Hirode, Grishma; Choi, Hannah S J; Chen, Chien-Hung; Su, Tung-Hung; Seto, Wai-Kay;

(...)

Kao, Jia-Horng; Cornberg, Markus; Hansen, Bettina E; Jeng, Wen-Juei; Janssen, Harry L A.

Referència: GASTROENTEROLOGY 2022.
Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions in the near future

Autors:
Rodriguez-Tajes, Sergio; Pocurull, Anna; Castillo, Joaquin; Casanova, Gherzon; Vega, Laia;

(...)

Marino, Zoe; Londono, Maria-Carlota; Forner, Alejandro; Torres, Ferran; Forns, Xavier.

Referència: JOURNAL OF HEPATOLOGY 2020.

Projectes destacats

Análisis transcriptómico espacial de las interacciones virus-huésped y la respuesta al tratamiento en la hepatitis crónica Delta (SPACE-D)

Investigador/a principal: Sabela Lens García, Xavier Forns Bernhardt

Finançador: Instituto de Salud Carlos III (ISCIII)

Codi: PI25/01234

Durada: 01/01/2026 - 31/12/2028
TherVacB: A therapeutic vaccine to cure hepatitis B

Investigador/a principal: Xavier Forns Bernhardt

Finançador: European Commission

Codi: 848223

Durada: 01/01/2020 - 31/12/2024

Web: https://www.thervacb.eu/
Exploring the mechanisms used by HBV to evade the host immune defenses

Investigador/a principal: Xavier Forns Bernhardt, XAvier Forns Sofia Pérez del Pulgar Thais Leonel Anna Pocurull Mala K. Maini Sergio Rodrígues-Tajes Ester Garcia Pras Ernest Belmonte, Sofia Pérez del Pulgar Xavier Forns

Finançador: ISCIII

Codi: PI22/00013

Durada: 01/01/2023 - 31/12/2025
Evaluación prospectiva de un modelo externalizado de consulta especializada con intervención educacional para reducir la reinfección por el virus de la hepatitis C en un centro de reducción de daños

Investigador/a principal: Xavier Forns Bernhardt, Xavier Forns Sergio Rodríguez Zoe Mariño Sabela Lens, Xavier Forns

Finançador: ISCIII

Durada: 01/01/2022 - 31/12/1964
Liver Vascular Biology and Hepatitis Research Group

Investigador/a principal: Jordi Gracia Xavier Forns, Jordi Gracia Sancho

Finançador: Generalitat Catalunya

Codi: PI22/00013

Durada: 01/01/2022 - 31/12/2025

Xavier Forns

Grup de recerca

Publicacions destacades

Projectes destacats

Análisis transcriptómico espacial de las interacciones virus-huésped y la respuesta al tratamiento en la hepatitis crónica Delta (SPACE-D)

TherVacB: A therapeutic vaccine to cure hepatitis B

Exploring the mechanisms used by HBV to evade the host immune defenses

Evaluación prospectiva de un modelo externalizado de consulta especializada con intervención educacional para reducir la reinfección por el virus de la hepatitis C en un centro de reducción de daños

Liver Vascular Biology and Hepatitis Research Group

Subscriu-te a la Newsletter del Clínic